Article
Molecular modelling of trimethoprim complexes of human wild-type and mutant dihydrofolate reductases: identification of two subsets of binding residues in the antifolate binding site.
Biopharmaceutics & drug disposition - 1 Oct 1999
Pan R, Bowen D, Southerland W M
Abstract excerpt
Computer-assisted molecular modelling was used to generate structures for the trimethoprim (TMP):NADPH:dihydrofolate reductase (DHFR) ternary complexes for human wild-type DHFR and for five DHFR mutants (L22R, L22F, F31S, F31W and Q35P). The mutants correspond to DHFR proteins that have been isolated from tissues exposed to chronic or high dose methotrexate (MTX) and show decreased sensitivity to antifolate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
